Caprion-HistoGeneX is now CellCarta

January 26, 2021

Our Singular Vision has a Bold New Name – CellCarta

CellCarta brings together (January 26, 2021) two leading contract research organizations in biomarker services: Caprion Biosciences, which specializes in immunology and proteomics services, and HistoGeneX, a provider of histopathology and genomics services.

The name CellCarta is inspired by the Magna Carta, a symbol of individual liberty, and is meant to evoke the company’s mission of mapping the content and function of human cells to enable and accelerate the evolution of precision medicine.

Integrated Expertise in Biomarker Services

CellCarta combines the strengths of Caprion Biosciences and HistoGeneX, creating a powerhouse in biomarker services. 

Our expertise spans immunology, proteomics, histopathology, and genomics, allowing us to deliver comprehensive solutions for precision medicine. By leveraging advanced technologies and a collaborative approach, we support pharmaceutical and biotech companies in developing targeted therapies and diagnostics.

Global Reach and Strategic Locations

With laboratories in key locations such as Montreal, Naperville, and global affiliates, CellCarta ensures accessibility and streamlined logistics for our clients. Our global network ensures swift processing of samples and data, enhancing the efficiency of clinical trials and research projects.

Career Opportunities at CellCarta

We are constantly seeking talented professionals to join our team. Explore career opportunities with CellCarta in various locations, including Canada and the USA. Whether you are interested in research, laboratory operations, or corporate roles, CellCarta offers a dynamic environment for career growth.

Commitment to Quality and Innovation

CellCarta is dedicated to maintaining the highest standards of quality and compliance. Our laboratories are CAP/CLIA certified, ensuring that all our processes meet rigorous regulatory requirements. 

We continuously invest in innovation and technology to stay at the forefront of scientific advancements, supporting the development of next-generation therapies.

Why Choose CellCarta?

CellCarta’s comprehensive approach to biomarker services, combined with our commitment to quality and innovation, makes us a trusted partner for the pharmaceutical and biotech industries. 

Our integrated expertise and global presence allow us to deliver precise, reliable data, driving the evolution of precision medicine.

For more information about our rebranding